Skip to content

Ex Vivo Study of the Heracure Device for Intra-uterine Morcellation After Vaginal or Laparoscopic Hysterectomy

Evaluation of the Heracure Device for Hysterectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05332132
Enrollment
10
Registered
2022-04-18
Start date
2022-04-18
Completion date
2022-12-31
Last updated
2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal or Laparoscopic Hysterectomy

Brief summary

Safety and performance evaluation of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

Detailed description

The purpose of this clinical investigation is to evaluate the safety and efficacy of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

Interventions

DEVICEHeracure Device

Intrauterine Morcellation of Uteri Post-Surgery (Ex Vivo Study)

Sponsors

Heracure Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject is undergoing hysterectomy due to benign gynecologic disease

Exclusion criteria

* Subject is not suspected of malignancy

Design outcomes

Primary

MeasureTime frameDescription
Device or procedure related Adverse Event (AE)Intra-operationAdverse Event defined as uterine perforation at the end of procedure, assessed by inflating the uterus with saline.

Secondary

MeasureTime frameDescription
Device SuccessIntra-operationDevice Success defined as the ability to reduce uterus size/circumference and the time required for performing the morcellation procedure

Countries

Israel

Contacts

Primary ContactGal Meister
galmeist1@gmail.com0549011128

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026